2Revathi G, Shannon KP, Stapleton P, et al. An outbreak of extended spectrum β-lactamase-producing salmonella in a burns ward.J Hosp Infect, 1998,40(4) : 295- 298.
3Shannon K, Stapleton P, Xiang X, et al, Extended spectrum β-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the united kindom.J Clin Microbiol, 1998, 36(10) : 3105-3107.
4Drusano GL. Infection in the intensive care unite, β-lactamase mediated resistance among entrobacteriaceae and optimal antimicrobial dosing. Clin Infect Dis, 1998,27(suppl) : S111-113.
5Cukier L, Lutzler P, Bizien A, et al. Investigation of an epidemic of an extended spectrum β-lactamase-producing escherichia coil in a geriatrics department. Pathol Biol, 1999, 47(5) : 440 - 443.
二级参考文献1
1Prof. Dr. A. Bauernfeind,G. H?rl. Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporins[J] 1987,Infection(4):257～259
1Knothe H, Shsh P, Krcmery V, et al. Transferable resistance tocefotaxime, cefoxitin, cefamandole and cefuroxime in clinicalisolates of Klebsiella pneumoniae and Serratia marcescens [J].Infection,1983,11(6): 315-317.
2Spellbei^ B, Guidos R, Gildert D, etal. The epidemic of antibiot-ic-resistant infections: a call to action for the medical communityfrom the Infectious Diseases Society of America [J]. Clin InfectDis, 2008,46(2): 155-164.
3Lautenbach E, Patal JB, Bilker WB, et al. Extended-spec-trum beta-lactamase-producing Escherichia coli and Klebsiellapneumoniae:risk factors for infection and impact of resistanceon outcomes [J], Clin Infect Dis, 2001, 32(8): 1162-1171.
